Skip to main content Skip to main navigation menu Skip to site footer
Journal of BioEngineering and Drug Administration
Journal of BioEngineering and Drug Administration

About The Journal

Bridging Innovation and Healthcare: Journal of BioEngineering and Drug Administration (JBDA) by Sciforce Publications

Step into the world of cutting-edge bioengineering and drug administration with the Journal of BioEngineering and Drug Administration (JBDA), a leading publication by Sciforce Publications. JBDA serves as a gateway to the latest research and advancements in the fields of bioengineering, drug development, and regulatory affairs. In this web content, we will explore the significance of JBDA, its contributions to the scientific community, and the dynamic realm of bioengineering and drug administration.

JBDA - Journal of BioEngineering and Drug Administration:

  • A Pillar of Excellence: Sciforce Publications is renowned for its unwavering commitment to scientific rigor and innovation, and JBDA is no exception. This journal stands at the forefront of disseminating groundbreaking research in bioengineering and drug administration.
  • Comprehensive Focus: JBDA covers a wide spectrum of topics within bioengineering and drug administration, including biomaterials, drug formulation, regulatory affairs, pharmaceutical engineering, and more. It serves as a comprehensive resource for multidisciplinary research.
  • Peer-Reviewed Rigor: Every article published in JBDA undergoes a rigorous peer-review process, ensuring that only high-quality, impactful research finds its place in the journal. This commitment to quality establishes JBDA as a trusted source of knowledge for researchers, pharmaceutical professionals, and regulatory experts.

Contributions to Scientific Advancement:

  • Cutting-edge Bioengineering: JBDA showcases pioneering research in bioengineering, including the development of innovative biomaterials, tissue engineering, and biotechnology applications aimed at advancing healthcare.
  • Drug Development and Formulation: The journal often features studies on drug formulation, delivery systems, and pharmaceutical engineering, addressing critical challenges in drug development and administration.
  • Regulatory Affairs: Research in JBDA explores regulatory affairs and compliance in the pharmaceutical and healthcare industries, providing insights into the evolving landscape of drug approval and administration.
  • Pharmaceutical Innovation: JBDA examines the latest innovations in pharmaceutical science, manufacturing, and quality control, contributing to the development of safer and more effective drugs.

Impact on Society:

The research published in the Journal of BioEngineering and Drug Administration has profound implications for society:

  • Enhanced Healthcare: Innovations in bioengineering and drug administration result in improved healthcare outcomes, including more efficient treatments, reduced side effects, and better patient care.
  • Drug Safety: The focus on regulatory affairs and quality control ensures that drugs and medical devices meet the highest safety standards, protecting patients and improving healthcare quality.
  • Scientific Progress: JBDA fosters scientific progress by providing a platform for researchers to share their discoveries and collaborate on innovative solutions in bioengineering and drug administration.
  • Sustainable Healthcare: Advances in drug formulation and administration can lead to more sustainable healthcare practices, reducing waste and optimizing resource use.

Our Mission:

At the Journal of BioEngineering and Drug Administration (JBDA) by Sciforce Publications, our mission is to be a driving force at the intersection of bioengineering and drug administration. We are dedicated to advancing scientific knowledge, fostering innovation in biomedical engineering, drug delivery, and regulatory affairs, and contributing to the development of cutting-edge technologies and strategies that improve healthcare outcomes.

Our mission is guided by several key principles:

  • Advancing Bioengineering and Drug Administration: We aim to push the boundaries of bioengineering and drug administration through pioneering research. Our mission is to provide a platform for the dissemination of groundbreaking studies that contribute to the understanding and development of innovative bioengineering solutions and drug administration technologies.
  • Empowering Healthcare Innovation: Healthcare innovation relies on the convergence of engineering and pharmaceutical sciences. We are committed to supporting research that empowers engineers, pharmaceutical scientists, researchers, and healthcare professionals to develop transformative technologies and strategies for healthcare delivery.
  • Promoting Scientific Excellence: Scientific excellence is at the core of our mission. We strive to uphold the highest standards of quality in bioengineering and drug administration research. Our goal is to provide a respected platform for researchers, engineers, scientists, and regulatory experts to share their pioneering work.
  • Bridging Research and Clinical Practice: We believe in the practical application of research. Our mission is to bridge the gap between laboratory discoveries and real-world applications, facilitating the translation of innovative bioengineering and drug administration solutions into clinical practice.
  • Global Impact: JBDA is dedicated to serving the global scientific community. Our mission is to provide a platform for researchers and professionals from around the world to share their insights, fostering international collaboration and knowledge exchange.
  • Ethical Conduct: We emphasize ethical conduct in bioengineering and drug administration research. Our mission is to promote the responsible and safe use of biomedical technologies and pharmaceuticals, ensuring patient safety and well-being.
  • Knowledge Dissemination: We recognize the power of knowledge dissemination. Our mission is to make high-quality bioengineering and drug administration research accessible to researchers, engineers, healthcare practitioners, educators, policymakers, and anyone interested in the field.

The Journal of BioEngineering and Drug Administration (JBDA) by Sciforce Publications is guided by a mission to pioneer innovation at the crossroads of bioengineering and drug administration. We are dedicated to expanding the frontiers of scientific knowledge, promoting transformative technologies, and contributing to the development of healthcare solutions that benefit patients, healthcare professionals, and society at large. Through our commitment to scientific excellence, ethical conduct, and global knowledge dissemination, we aspire to make a meaningful impact on the fields of bioengineering and drug administration, driving healthcare innovation for a healthier and more advanced future. Join us in our mission to advance bioengineering and drug administration for the betterment of healthcare and society.

 Aim and Scope 

Journal of BioEngineering and Drug Administration (JBDA) of Sciforce Publications is an interdisciplinary field of Pharmaceutical Chemistry. JBDA publishes original research articles, book chapters, reviews, letters and short communications, rapid communications, and abstracts. Bioengineering is the application of principles of biology and the tools of engineering to create usable, tangible, economically-viable products. Biological engineering employs knowledge and expertise from a number of pure and applied sciences such as mass and heat transfer, kinetics, biocatalysts, biomechanics, bioinformatics, separation and purification processes, bioreactor design, surface science, fluid mechanics, thermodynamics, and polymer science. It is used in the design of medical devices, diagnostic equipment, biocompatible materials, renewable bioenergy, ecological engineering, agricultural engineering, and other areas that improve the living standards of societies. Bioengineering research includes bacteria engineered to produce chemicals, new medical imaging technology, portable and rapid disease diagnostic devices, prosthetics, biopharmaceuticals, and tissue-engineered organs. Bioengineering overlaps substantially with biotechnology and the biomedical sciences in a way analogous to how various other forms of engineering and technology relate to various other sciences such as aerospace engineering and other space technology to kinetics and astrophysics. Biological engineers or biomedical engineers  attempt to either mimic biological systems to create products or modify and control biological systems so that they can replace, augment, sustain, or predict chemical and mechanical processes. Bioengineers can apply their expertise to other applications of engineering and biotechnology, including genetic modification of plants and microorganisms, bioprocess engineering, and biocatalysis.  

Journal of BioEngineering and Drug Administration (JBDA) publish journals and research papers are a gateway to the community Pharmaceutical science experts, researchers and peers. While adhering to the international standards of online publishing, JBDA aims to publish high quality, informative, scientific and well-researched content.

Journal of BioEngineering and Drug Administration (JBDA) Research Topics 

  • Drug development sciences
  • Therapeutic bioengineering
  • ADME Toxicity
  • Anticancer Drug Development
  • Antidiabetic Drugs
  • Antigen Antibody Reaction
  • Antimicrobial Drug Development
  • Binding free energy estimation
  • Binding site prediction
  • Bioavailability
  • Bioequivalence
  • Biopharmaceutics
  • Chemical Diversity
  • Chemical structure representations
  • Chemo informatics
  • Clinical Pharmacology
  • Combinatorial library design
  • Compound Management
  • Computational Chemistry
  • Computer-assisted Drug Design
  • Contraindications
  • Database Mining and Data Analysis
  • Docking
  • Drug Delivery Systems
  • Drug Delivery using Nanotechnology
  • Drug Designing
  • Drug Development Research
  • Drug Metabolism
  • Drug Research and Discovery Process
  • Drug Stability
  • Drug Targeting
  • Drug-drug and Drug-chemical Interactions
  • Fragment Based Drug Design
  • Heat Shock Proteins
  • Herbal Drug Development
  • High throughput Screening
  • Homology Modeling
  • In Silico Methods
  • Ligand design
  • Ligand-Based Drug Design Approaches and Examples
  • Medicinal Chemistry
  • Metabolomics
  • Molecular Docking
  • Molecular Drug Design
  • Molecular Mechanics and Quantum Mechanics
  • Molecular Modeling
  • Molecular Modelling
  • Nanomedicals
  • Nanopharmaceutics
  • Neuropharmacology
  • New Molecular Entity
  • Orphan Drug
  • Overdose
  • Peptidomimetic
  • Pharmaceutical Chemistry
  • Pharmaceutical Nanotechnology
  • Pharmaceutical Toxicology
  • Pharmaceutics
  • Pharmacodynamics
  • Pharmacoepidemiology
  • Pharmacogenetics
  • Pharmacogenomics
  • Pharmacognosy
  • Pharmacokinetics
  • Pharmacology
  • Pharmacophore modeling in drug design
  • Pharmacophores
  • Pharmacovigilance
  • Phases of Drug Development
  • Physiologically-based pharmacokinetic modelling
  • Posology
  • Preclinical Drug Development
  • Prodrug
  • Protease Substrate/Inhibitor
  • Protein modeling and Structural genomics
  • Psychopharmacology
  • QSAR
  • Quantitative structure-activity Relationship (QSAR)
  • Receptor Agonist/ Antagonist
  • Screening and Drug Design
  • Side effects
  • Simcyp Simulator
  • Structure-activity Relationships
  • Structure-Based Molecular Design
  • Synthetic Chemistry
  • Target prediction
  • Therapeutic Window
  • Translational Drug Development

The Journal of BioEngineering and Drug Administration by Sciforce Publications is a beacon of knowledge in the dynamic fields of bioengineering and drug administration. Its dedication to scientific excellence, innovation, and impactful research makes it an indispensable resource for scientists, researchers, pharmaceutical professionals, and regulatory experts. Explore the pages of JBDA to stay updated on the latest developments and breakthroughs in bioengineering and drug administration, and join the journey toward a healthier and more efficient healthcare landscape.